| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2022 | Jul 5, 2022 | Protara Therapeutics, Inc. | Director | Buy | 86.3 | +10,000 | 5.32% | ✗ | $31K |
| Mar 14, 2022 | Mar 16, 2022 | Protara Therapeutics, Inc. | Director | Buy | 86.3 | +10,000 | 5.62% | ✗ | $42.5K |
| Mar 10, 2022 | Mar 14, 2022 | Protara Therapeutics, Inc. | Director | Buy | 86.3 | +10,000 | 5.95% | ✗ | $44.6K |
| Nov 29, 2018 | Dec 3, 2018 | REGENXBIO Inc. | Director | Sell | 7.5 | -12,784 | -100.00% | ✓ | $831K |
| Nov 26, 2018 | Nov 28, 2018 | REGENXBIO Inc. | Director | Sell | 5.0 | -20,507 | -100.00% | ✓ | $1.3M |
| Nov 19, 2018 | Nov 21, 2018 | REGENXBIO Inc. | Director | Sell | 5.0 | -33,292 | -94.87% | ✓ | $2M |